REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/14/2025
Back to search
Official data from USPTO
CTI BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
06/15/2025
Classification
Registered
Trademark type
Combined
Nice classes
42
Filing date
08/06/2014
Registration date
06/14/2016
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/30/2021
Last transaction
06/15/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/31/2014
First use in commerce
05/31/2014
Drawing code
3
Owner type
03
Owner location
SEATTLE, WA
Examiner
LEE,YATSYE ISADORA
Law office
L70
Current location
TMEG LAW OFFICE 107
Mark description
The mark consists of a stylized image of a stick figure design to the left hand side of the wording "CTI BIOPHARMA".
Holders and representatives
Holders
CTI BIOPHARMA CORP.
CTI BIOPHARMA CORP.
Representatives
Frances M. Jagla CHRISTENSEN O'CONNOR JOHNSON KINDNESS PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Researchdevelopmentengineeringtestingproduct evaluationinspection in the field of pharmaceutical preparations and products; pharmaceutical research and development; providing technical consultation in the field of pharmaceutical product research and development; medical and scientific researchconducting clinical trials for others for pharmaceutical preparations used for the treatment of cancerimmunologicalinflammatory and infectious diseasespain; scientific researchconsultingadvice in the fields of biotechnologypharmaceutical research and developmentthe life sciences; pharmaceuticalmedical and laboratory research services in the fields of pharmaceuticalscancergenetic disordersthe life sciences; providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticalsthe life sciencesclinical trialsmedicineoncologyhematologycancerdisease classificationgenetic disorders; and consultation related to the foregoing
Publications
History of USPTO decisions and trademark events.
54 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/30/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/30/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/30/2021
E815
TEAS SECTION 8 & 15 RECEIVED
06/16/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/14/2021
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
06/15/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/14/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/14/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/14/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/14/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/14/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/06/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/06/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/06/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/06/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
06/14/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/10/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/07/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/06/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/06/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/15/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/14/2016
DPCC
DIVISIONAL PROCESSING COMPLETE
04/14/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/12/2016
IUAF
USE AMENDMENT FILED
02/23/2016
DRRR
DIVISIONAL REQUEST RECEIVED
02/23/2016
EISU
TEAS STATEMENT OF USE RECEIVED
02/23/2016
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
02/23/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/26/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/01/2015
PUBO
PUBLISHED FOR OPPOSITION
12/01/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/11/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/29/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/26/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/20/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/19/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/19/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/29/2015
GNFR
FINAL REFUSAL E-MAILED
04/29/2015
CNFR
FINAL REFUSAL WRITTEN
04/29/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/12/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2015
ALIE
ASSIGNED TO LIE
03/05/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/25/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/31/2014
GNRT
NON-FINAL ACTION E-MAILED
08/31/2014
CNRT
NON-FINAL ACTION WRITTEN
08/31/2014
DOCK
ASSIGNED TO EXAMINER
08/31/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/16/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/15/2014
NWAP
NEW APPLICATION ENTERED
08/09/2014
Continuous trademark protection
Get notified about every new filing that threatens CTI BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.